BACKGROUND	This randomised , double-blind , double-dummy , parallel-group multicentre study assessed the impact of a total daily dose of 60-80 mg oral oxycodone prolonged-release ( PR ) / naloxone PR ( OXN PR ) as fixed-ratio combination for patients with opioid-induced constipation ( OIC ) having moderate-to-severe , non-malignant pain .\